Role of Blood-Brain Barrier in Alzheimer’s Disease
The DOI matches its Crossref record; 133 of the 133 references it cites were found in a registry or an index.
Abstract
The blood-brain barrier (BBB) is involved in the pathogenesis of Alzheimer's disease (AD). BBB is a highly selective semipermeable structural and chemical barrier which ensures a stable internal environment of the brain and prevents foreign objects invading the brain tissue. BBB dysfunction induces the failure of Aβ transport from brain to the peripheral circulation across the BBB. Especially, decreased levels of LRP-1 (low density lipoprotein receptor-related protein 1) and increased levels of RAGE (receptor for advanced glycation endproducts) at the BBB can cause the failure of Aβ transport. The pathogenesis of AD is related to the BBB structural components, including pericytes, astrocytes, vascular endothelial cells, and tight junctions. BBB dysfunction will trigger neuroinflammation and oxidative stress, then enhance the activity of β-secretase and γ-secretase, and finally promote Aβ generation. A progressive accumulation of Aβ in brain and BBB dysfunction may become a feedback loop that gives rise to cognitive impairment and the onset of dementia. The correlation between BBB dysfunction and tau pathology has been well-reported. Therefore, regulating BBB function may be a new therapeutic target for treating AD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
The blood-brain barrier/neurovascular unit in health and disease
Hawkins, B. T., & Davis, T. P. (2005) · Pharmacological Reviews · doi:10.1124/pr.57.2.4 · Cited by 2,661 · cited 2×
“TheBBBhasthemostimpor-tantroleinmaintainingbrainfunctionamongthe threebrainbarriers[14,15].”
The blood–brain barrier: an overview
Ballabh, P., Braun, A., & Nedergaard, M. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2003.12.016 · Cited by 2,261
Blood-brain barrier breakdown in the aging human hippocampus
Montagne, A., Barnes, S. R., Sweeney, M. D., Halliday, M. R., Sagare, A. P., Zhao, Z., Toga, A. W., Jacobs, R. E., Liu, C. Y., Amezcua, L., et al. (2015) · Neuron · doi:10.1016/j.neuron.2014.12.032 · Cited by 2,102
Establishment and Dysfunction of the Blood-Brain Barrier
Zhao, Z., Nelson, A. R., Betsholtz, C., & Zlokovic, B. V. (2015) · Cell · doi:10.1016/j.cell.2015.10.067 · Cited by 1,670 · cited 1×
“Pericytes, an important component of neurovascular unit and BBB, act like the gatekeepers of the BBB, and exquisitely regulate the movement of brain cellsandthetransportationofnutrientsandmoleculesbetweenthebloodandthebraininterstitialfluidthatsurroundsthebraincells [87–89].”
RAGE mediates amyloid-β peptide transport across the blood-brain barrier and accumulation in brain
Deane, R., Du Yan, S., Submamaryan, R. K., LaRue, B., Jovanovic, S., Hogg, E., Welch, D., Manness, L., Lin, C., Yu, J., et al. (2003) · Nature Medicine · doi:10.1038/nm890 · Cited by 1,611
Molecular physiology and pathophysiology of tight junctions in the blood–brain barrier
Huber, J. D., Egleton, R. D., & Davis, T. P. (2001) · Trends in Neurosciences · doi:10.1016/s0166-2236(00)02004-x · Cited by 786 · cited 1×
“…or progression of numerous brain diseases, such as hemorrhagic and ischemic stroke, intracranial infectious diseases, intracranial autoimmune diseases, epilepsy, lupus cerebritis, and brain tumors [105, 106], as well as neurodegenerative diseases like Parkinson’s disease and AD [45, 107].”
The blood-brain barrier in Alzheimer’s disease
Zenaro, E., Piacentino, G., & Constantin, G. (2017) · Neurobiology of Disease · doi:10.1016/j.nbd.2016.07.007 · Cited by 767 · cited 7×
“Second,A (cid:2) pathology suffering from BBB dysfunction can indirectly facilitate the onset of tau pathology, representing a mechanistic link between A (cid:2) /tau deposition after BBB dysfunction [1, 126].”
InfluentialAlzheimer’s disease: A matter of blood–brain barrier dysfunction?
Montagne, A., Zhao, Z., & Zlokovic, B. V. (2017) · Journal of Experimental Medicine · doi:10.1084/jem.20171406 · Cited by 672 · cited 2×
“528 Yet, the role of BBB in the pathogenesis of AD is 529 still a challenge [12, 132].”
Bell, R. D., Sagare, A. P., Friedman, A. E., Bedi, G. S., Holtzman, D. M., Deane, R., & Zlokovic, B. V. (2007) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600419 · Cited by 670
Halliday, M. R., Rege, S. V., Ma, Q., Zhao, Z., Miller, C. A., Winkler, E. A., & Zlokovic, B. V. (2016) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2015.44 · Cited by 649
Research works printed but not linked: 1
- Volpina, 2015, [Fragment of receptor for advanced glycation end products improves memory state in a model of Alzheimer’s disease, Bioorg Khim, 41, 709
Cited by
Items 101–200 of 376
Liu, Y., Lü, X., Chen, M., Wei, Z., Peng, G., Yang, J., Tang, C., & Yu, P. (2023) · BioFactors · doi:10.1002/biof.2001 · Cited by 31
Feng, X., Jiang, B., Zhai, S.-N., Liu, C., Wu, H., Zhu, B.-Q., Wei, M.-Y., Wei, J., Yang, L. C., & Chen, L. (2025) · Nature Biotechnology · doi:10.1038/s41587-025-02624-w · Cited by 48
“Moreover, microglia (CD11b + ) are the major contributors to neuroinflammation 10,11 , secreting proinflammatory cytokines dozens of times higher than CD11b − samples in 5xFAD mice (Extended Data Fig.”
Increased CSF-decorin predicts brain pathological changes driven by Alzheimer’s Aβ amyloidosis
Jiang, R., Smailović, U., Haytural, H., Tijms, B. M., Li, H., Haret, R. M., Shevchenko, G., Chen, G., Abelein, A., Gobom, J., et al. (2022) · Acta Neuropathologica Communications · doi:10.1186/s40478-022-01398-5 · Cited by 35
“Decreased CSF production has been reported in AD [4] due to dysfuncional BCSFB which may lead to imparied Aβ clearance from brain to the peripheral circulation, hence aggravating Aβ accumulation in the brain that further increases BBB dysfuntion [5].”
BackgroundApplication of nanomaterials in diagnosis and treatment of glioblastoma
Yu, S., Chen, L., Xu, H., Long, S., Jiang, J., Wei, W., Niu, X., & Li, X. (2022) · Frontiers in Chemistry · doi:10.3389/fchem.2022.1063152 · Cited by 32
“Meanwhile, the blood-brain barrier (BBB), a highly selective semipermeable structural and chemical barrier (Cai et al., 2018), hinders drug delivery to the brain.”
BackgroundKelly, L., Brown, C., Michalik, D., Hawkes, C. A., Aldea, R., Agarwal, N., Salib, R. J., Alzetani, A., Ethell, D. W., Counts, S., et al. (2023) · Alzheimer s & Dementia · doi:10.1002/alz.13512 · Cited by 34
Junyi, L., Yueyang, W., Liu, B., Xiaohong, D., Wenhui, C., Zhang, N., & Zhang, H. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-04513-w · Cited by 34
“(iii) Other pathological mechanisms [3, 37, 38]: Apart from the aforementioned factors, various elements including the modification of tau proteins, the integrity of the BBB, the autophagy-lysosomal pathway, mitochondrial function, cholinergic transmission, oxidative stress, and genetic…”
Kulczyńska‐Przybik, A., Słowik, A., Mroczko, P., Borawski, B., Groblewska, M., Borawska, R., & Mroczko, B. (2020) · Current Alzheimer Research · doi:10.2174/1567205017666201109095657 · Cited by 32
The neuroprotective effects of oxygen therapy in Alzheimer’s disease: a narrative review
Le, W., Yang, C., Yang, Q., Xiang, Y., Zeng, X., & Xiao, J. F. (2022) · Neural Regeneration Research · doi:10.4103/1673-5374.343897 · Cited by 35
Leikin-Frenkel, A. I., Beeri, M. S., & Cooper, I. (2022) · Nutrients · doi:10.3390/nu14235091 · Cited by 31
“These membrane characteristics have direct influence on the function of receptors and transporters expressed in brain endothelial cells, which have a crucial role in AD pathophysiology [35,36].”
BackgroundSerum zonulin levels are increased in Alzheimer’s disease but not in vascular dementia
Boschetti, E., Caio, G., Cervellati, C., Costanzini, A., Rosta, V., Caputo, F., GIORGIO, R. D., & Zuliani, G. (2023) · Aging Clinical and Experimental Research · doi:10.1007/s40520-023-02463-2 · Cited by 31
“Moreover, BBB dysfunction can trigger neuroinflammation and oxidative stress, which enhance the activity of β- and γ-secretase promoting Aβ generation [37].”
BackgroundIdentification of Immune Cells and Key Genes associated with Alzheimer's Disease
Liu, C., Zhang, X., Chai, H., Xu, S., Liu, Q., Luo, Y., & Li, S. (2021) · International Journal of Medical Sciences · doi:10.7150/ijms.66422 · Cited by 37
“Microglia and astrocytes are actively involved in the immune response of the Central Nervous System (CNS) [7, 8].”
BackgroundInfluentialHong, Y., Wei, C., Fu, M., Li, X., Zhang, H., & Yao, B. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.111236 · Cited by 29
Macrophage migration inhibitor factor (MIF): Potential role in cognitive impairment disorders
Zeng, L., Hu, P., Zhang, Y., Li, M., Zhao, Y., Li, S., & Luo, A. (2024) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2024.03.003 · Cited by 31
Johnson, T. S., Xiang, S., Dong, T., Huang, Z., Cheng, M., Wang, T., Yang, K., Ni, D., Huang, K., & Zhang, J. (2021) · Scientific Reports · doi:10.1038/s41598-020-79740-x · Cited by 38
Diabetic retinopathy and dementia association, beyond diabetes severity
Lee, C. S., Krakauer, C., Su, Y.-R., Walker, R. L., Blazes, M., McCurry, S. M., Bowen, J. D., McCormick, W. C., Lee, A. Y., Boyko, E. J., et al. (2023) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2022.12.003 · Cited by 25
Effect of β-amyloid on blood-brain barrier properties and function
Petrushanko, I. Y., Mitkevich, V. A., & Makarov, A. А. (2023) · Biophysical Reviews · doi:10.1007/s12551-023-01052-x · Cited by 29
Contribution of cerebral microvascular mechanisms to age-related cognitive impairment and dementia
Fang, X., Crumpler, R. F., Thomas, K. N., Mazique, J. N., Roman, R. J., & Fan, F. (2022) · Physiology International · doi:10.1556/2060.2022.00020 · Cited by 26
Liu, L., Hu, Y. H., Liu, Y., Shi, D.-W., Liu, C., Da, X., Zhu, S.-H., Zhu, Q., Zhang, J., & Xu, G. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.1021129 · Cited by 28
“BBB disruption is a consistent pathological feature of several neurodegenerative diseases associated with cognitive decline (Cai et al., 2018).”
BackgroundQuillen, D., Hughes, T. M., Craft, S., Howard, T. D., Register, T. C., Suerken, C. K., Hawkins, G. A., & Milligan, C. (2023) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000200095 · Cited by 26
“The negative feedback loop between amyloid accumulation, tau phosphorylation, and BBB function has been hypothesized to contribute to the onset of AD.38 Thus, BBB dysfunction, due to increased age or increased IL6 trans-signaling, appears to be playing a role in cognitive impairment and dementia, allowing systemic inc…”
BackgroundInfluentialNeuroinflammation: A Common Pathway in Alzheimer’s Disease and Epilepsy
Liew, Y., Retinasamy, T., Arulsamy, A., Ali, I. Y., Jones, N. C., O'Brien, T. J., & Shaikh, M. F. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-230059 · Cited by 30
“Furthermore, disruption in the BBB that happens in both AD and epilepsy was hypothesized as a consequence of the proinflammatory response [57].”
BackgroundDumitrascu, O. M., Doustar, J., Fuchs, D.-T. S., Koronyo, Y., Sherman, D. S., Miller, M. S., Johnson, K., Carare, R. O., Verdooner, S. R., Lyden, P. D., et al. (2024) · Acta Neuropathologica Communications · doi:10.1186/s40478-024-01810-2 · Cited by 25
Aryal, R., & Patabendige, A. (2021) · Open Biology · doi:10.1098/rsob.200396 · Cited by 27
“Hence potential treatments focusing on BBB protection could be beneficial in the treatment of Alzheimer’s disease [65].”
BackgroundReversal of cerebral hypoperfusion: a novel therapeutic target for the treatment of AD/ADRD?
Fan, F., & Roman, R. J. (2021) · GeroScience · doi:10.1007/s11357-021-00357-7 · Cited by 25
Advanced Glycation End Products in Neurodegenerative Diseases
Raghavan, C. T. (2024) · Journal of Molecular Neuroscience · doi:10.1007/s12031-024-02297-1 · Cited by 26
“Increased Aβ availability within the brain then could result in neurotoxicity via diverse mechanisms, including neuroinflammation and impairment of receptors for various neurotransmitters (Derk et al. 2018; Cai et al. 2018).”
Central nervous system vascularization in human embryos and neural organoids
Boutom, S., Silva, T. P., Palecek, S. P., Shusta, E. V., Fernandes, T. G., & Ashton, R. S. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.115068 · Cited by 27
Nanotechnology-based gene therapy as a credible tool in the treatment of Alzheimer’s disease
Unnisa, A., Greig, N. H., & Kamal, M. (2023) · Neural Regeneration Research · doi:10.4103/1673-5374.369096 · Cited by 24
“The accumulation of Aβ in the brain combined with BBB malfunction creates a feedback loop that leads to amyloid oligomers and plaque development (Cai et al., 2018), the triggering of tau hyperphosphorylation and other aberrant cascades and, ultimately, cognitive decline and dementia (de Oliveira et al.”
BackgroundSun, R., Feng, J., & Wang, J. (2023) · Aging and Disease · doi:10.14336/ad.2023.0621 · Cited by 28
“Receptors for advanced glycation end products (RAGE) and low-density lipoprotein receptor-related protein 1 (LRP1) are involved in Aβ transport and are elevated in expression in age-related BBB [185].”
BackgroundLiang, J., Liu, B., Dong, X., Wang, Y., Cai, W., Zhang, N., & Zhang, H. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1242254 · Cited by 29
“These fissures in the robustness of BBB integrity bestow passage to molecules of an inflammatory nature and immune effectors, thereby augmenting the overall inflammatory milieu characterizing AD (Blair et al., 2015; Cai et al., 2018).”
Ding, Y., Palecek, S. P., & Shusta, E. V. (2024) · Fluids and Barriers of the CNS · doi:10.1186/s12987-024-00580-2 · Cited by 23
“…by clinical studies is whether the enhanced BBB dysfunction in APOE4 carriers is a result of intrinsic deficiencies in BMECs or pericytes, or a result of chronic exposure to APOE4 -producing astrocytes, enhanced neuroinflammation, or other pathologies associated with APOE4 carriers [2, 4].”
BackgroundChang, L., Hu, L., Wei, C., Zhang, H., & Liu, S. (2020) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2020.105071 · Cited by 23
Blood brain barrier-on-a-chip to model neurological diseases
Reshma, S. C., Megha, K. B., Amir, S., Rukhiya, S., & Mohanan, P. V. (2023) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2023.104174 · Cited by 24
Vitamin D, Calbindin, and calcium signaling: Unraveling the Alzheimer's connection
Acharya, M., Singh, N., Gupta, G., Tambuwala, M. M., Aljabali, A. A. A., Chellappan, D. K., Dua, K., & Goyal, R. (2024) · Cellular Signalling · doi:10.1016/j.cellsig.2024.111043 · Cited by 25
Machado, G. D. B., de Freitas, B. S., Florian, L. Z., Monteiro, R. T., Gus, H., & Schröder, N. (2019) · Journal of Neuroendocrinology · doi:10.1111/jne.12780 · Cited by 25
Alzheimer’s disease: from early pathogenesis to novel therapeutic approaches
Prajapati, S. K., Pathak, A., & Samaiya, P. K. (2024) · Metabolic Brain Disease · doi:10.1007/s11011-024-01389-6 · Cited by 21
“APOE maintains homeostasis in cerebral region by regulating lipid transport through the BBB (Calderón-Garcidueñas et al. 2019 ).”
InfluentialWang, S., Song, H., Yin, C., & Huo, F. (2025) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2025.216940 · Cited by 23
Photostimulation of Extravasation of Beta-Amyloid through the Model of Blood-Brain Barrier
Zinchenko, E. M., Klimova, M., Mamedova, A., Agranovich, I., Blokhina, I., Antonova, T., Terskov, A. V., Shirokov, A. A., Наволокин, Н. А., Morgun, A. V., et al. (2020) · Electronics · doi:10.3390/electronics9061056 · Cited by 22
“The important role of the BBB in the development and progression of AD has also been shown by other researchers [33].”
ResultZhao, L., Wang, Z.-T., Ma, Y., Zhang, W., Dong, Q., Yu, J., Tan, L., & Initiative, A. D. N. (2021) · BMC Neurology · doi:10.1186/s12883-021-02356-9 · Cited by 26
Li, M., Sun, Z., Sun, H., Zhao, G., Leng, B., Shen, T., Xue, S., Hou, H., Li, Z., & Zhang, J. (2022) · Alzheimer s Research & Therapy · doi:10.1186/s13195-022-01153-x · Cited by 26
“BBB dysfunction triggers neuroinflammation and oxidative stress and then promotes Aβ generation, giving rise to cognitive impairment and the onset of dementia [41].”
BackgroundSun, Y., Ho, C., & Zhang, X. (2023) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.2c07742 · Cited by 23
Shah-abadi, M. E., Ariaei, A., Moradi, F., Rustamzadeh, A., Tanha, R. R., Sadigh, N., Marzban, M., Heydari, M., & Ferdousie, V. T. (2023) · Neurotoxicity Research · doi:10.1007/s12640-023-00648-1 · Cited by 22
“In the transporting aspect, low-density lipoprotein receptor-related protein 1 (LRP1) and receptor for advanced glycation end-products (RAGE) have two contradicting functions in the blood–brain barrier (BBB), in which LRP1 participates in the efflux of Aβ from interstitial fluid (Cai et al. 2018).”
BackgroundAcupuncture therapy for Alzheimer's disease: The effectiveness and potential mechanisms
Yin, W., Lv, G., Li, C., & Sun, J. (2021) · The Anatomical Record · doi:10.1002/ar.24780 · Cited by 26
Emerging role of Metformin in Alzheimer’s disease: A translational view
Ríos, J. A., Bórquez, J. C., Godoy, J. A., Zolezzi, J. M., Furrianca, M. C., & Inestrosa, N. C. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102439 · Cited by 24
Rouhi, N., Chakeri, Z., Ghorbani Nejad, B., Rahimzadegan, M., Rafi Khezri, M., Kamali, H., & Nosrati, R. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e37533 · Cited by 20
“Challenges in treating AD have partially arisen from difficulties in penetrating the BBB [37,38].”
BackgroundAyoub, S., Arabi, M., Al-Najjar, Y. A., Laswi, I., Outeiro, T. F., & Châari, A. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-05051-9 · Cited by 27
“Notably, AGEs derived from dry-heat-cooked foods significantly elevate the risk of age-related diseases by RAGE, a key mediator in chronic inflammatory and degenerative conditions [88, 89].”
miR-485-5p alleviates Alzheimer’s disease progression by targeting PACS1
He, C. H., Su, C., Zhang, W., & Wan, Q. (2021) · Translational Neuroscience · doi:10.1515/tnsci-2020-0177 · Cited by 22
Tang, M.-Y., Gorin, F. A., & Lein, P. J. (2022) · Ageing and Neurodegenerative Diseases · doi:10.20517/and.2022.05 · Cited by 25
Gong, M., & Jia, J. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.949129 · Cited by 20
“BBB failure is considered to be a core mechanism in vascularrelated diseases and neurodegenerative dementia, driving disease pathology and progression (Yamazaki and Kanekiyo, 2017; Cai et al., 2018; Ueno et al., 2019; Uemura et al., 2020).”
BackgroundIs blood pTau a reliable indicator of the CSF status? A narrative review
Antonioni, A., Raho, E. M., & Lorenzo, F. D. (2023) · Neurological Sciences · doi:10.1007/s10072-023-07258-x · Cited by 21
“Indeed, pathological brain proteins cross the blood–brain barrier (BBB) and pass from the CSF to the blood compartment, to an increasing extent as damage and dysfunction of the BBB progresses [11, 12].”
Disease-directed engineering for physiology-driven treatment interventions in neurological disorders
Wood, T. R., & Nance, E. A. (2019) · APL Bioengineering · doi:10.1063/1.5117299 · Cited by 21
Yang, C., Mo, Y., Chen, H., Huang, Y., Li, S., Wang, H., Huang, S., Chang, X., Du, Q., & Wang, Q. (2021) · Journal of Integrative Neuroscience · doi:10.31083/j.jin2002025 · Cited by 21
“Second, apart from neurons, RAGE and LRP1 are extensively expressed in microglia and endothelial cells [41].”
BackgroundThe interplay of neurovasculature and adult hippocampal neurogenesis
Kim, T. A., Chen, L., & Ge, S. (2021) · Neuroscience Letters · doi:10.1016/j.neulet.2021.136071 · Cited by 23
“The BBB is one of the most important part of brain vasculature and abnormalities have been found to be associated with a variety of pathological conditions such as Alzheimer’s disease, stroke, epilepsy and neuroinflammation [16, 53, 88, 121, 138].”
BackgroundO-Glycome Profiling of Breast Cancer Cell Lines to Understand Breast Cancer Brain Metastasis
Onigbinde, S. B., Peng, W., Reddy, A., Cho, B. G., Goli, M., Solomon, J., Adeniyi, M., Nwaiwu, J. I., Fowowe, M., Daramola, O. E., et al. (2024) · Journal of Proteome Research · doi:10.1021/acs.jproteome.3c00914 · Cited by 21
Interactions between Beta-Amyloid and Pericytes in Alzheimer’s Disease
Li, Y.-Y., Guo, D.-D., Duan, R., & Li, Y. (2024) · Frontiers in Bioscience-Landmark · doi:10.31083/j.fbl2904136 · Cited by 19
“The expression of LRP-1 is downregulated in AD patients exacerbating A β pathology [90].”
BackgroundApplication of Nanomaterials in Neurodegenerative Diseases
Cui, W., Fu, W., Lin, Y., & Zhang, T. (2020) · Current Stem Cell Research & Therapy · doi:10.2174/1574888x15666200326093410 · Cited by 23
Role of Blood-Brain barrier in bacterial translocation
Aborode, A. T., Adesola, R. O., Scott, G. Y., Adepoju, V. A., Akan, O. D., Ogunyemi, A. D., Adetunji, A. P.-G., Arogundade, F. Q., Kwaku, S. D., Emmanuel, A. O., et al. (2025) · Neuroscience · doi:10.1016/j.neuroscience.2025.06.037 · Cited by 20
Abikenari, M. A., Sjöholm, M., Liu, J., Nageeb, G., Ha, J. H., Wu, J. Y., Ren, A. L., Sayadi, J. J., Lim, J., Cho, K. B., et al. (2025) · Frontiers in Physics · doi:10.3389/fphy.2025.1723329 · Cited by 21
Cheng, Z., Dai, L., Wu, Y., Cao, Y., Chai, X., Wang, P., Liu, C., Ni, M., Gao, F., Wang, Q., et al. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2023.1077860 · Cited by 18
Yan, C., Gu, J., Yin, S., Wu, H., Lei, X., Geng, F., Zhang, N., & Wu, X. (2023) · Journal of drug targeting · doi:10.1080/1061186x.2023.2290453 · Cited by 22
“…and other potentially harmful environmental insults [7–9]. however, it also prevents diagnostic and therapeutic drugs from entering the brain [10]. as a result, finding a multi-target agent is required urgently to combat aD. the neuroprotective effects of naringenin make it a promising…”
BackgroundGuo, X., Liu, H. N., Song, Y., Wang, J., Liu, D., Zheng, Z., Li, J., Li, B., Song, A., He, W., et al. (2026) · MedComm · doi:10.1002/mco2.70497 · Cited by 32
Cerasuolo, M., Papa, M., Colangelo, A. M., & Rizzo, M. R. (2023) · Biomedicines · doi:10.3390/biomedicines11030861 · Cited by 18
“They are mainly located on the surface of endothelial cells and pericytes [38].”
BackgroundAmyloid-beta metabolism in age-related neurocardiovascular diseases
Aivalioti, E., Georgiopoulos, G. A., Tual‐Chalot, S., Bampatsias, D., Delialis, D., Sopova, K., Drakos, S. G., Stellos, K., & Stamatelopoulos, K. S. (2024) · European Heart Journal · doi:10.1093/eurheartj/ehae655 · Cited by 24
Roles of Exosomes and Exosomal MicroRNAs in Postoperative Sleep Disturbance
Gu, X., & Zhu, J. (2021) · Nature and Science of Sleep · doi:10.2147/nss.s310351 · Cited by 16
Resmi, A. N., Rekha, C. R., Dhushyandhun, M. E., Sarathkumar, E., Shenoy, S. J., Gulia, K. K., & Jayasree, R. S. (2023) · Journal of Materials Chemistry B · doi:10.1039/d2tb02802f · Cited by 16
Gan, J., Yang, X., Zhang, G., Li, X., Liu, S., Zhang, W., & Ji, Y. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1088140 · Cited by 20
“Furthermore, the interactive and facilitative effects between neuropathological biomarkers of AD and BBB disruption cause oxidation, proinflammatory signaling, and endothelial damage to further negatively affect the pathway (Cai et al., 2018; Michalicova et al., 2020; Custodia et al., 2021; Kurz et al., 2022).”
BackgroundLiu, J., Xie, Y., Lu, Y., Zhao, Z., Zhuang, Z., Yang, L., Huang, H., Li, H., Mao, Z., Pi, S., et al. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-221205 · Cited by 17
“The LRP-1 protein is an important ligand protein that is present in the BBB and is responsible for transporting A (cid:2) between the brain and the blood [28, 29].”
Faissner, A. (2023) · Frontiers in Network Physiology · doi:10.3389/fnetp.2023.1190240 · Cited by 17
The Role of microRNAs in Epigenetic Regulation of Signaling Pathways in Neurological Pathologies
Tregub, P. P., Ibrahimli, I., Сергеевич, А. А., Salmina, A. B., Litvitskiy, P. F., Manasova, Z. S., & Popova, I. A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241612899 · Cited by 18
Jain, U., Johari, S., & Srivastava, P. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03671-7 · Cited by 17
“Furthermore, the blood-brain barrier (BBB) dysfunction can also be the prime reason for the development and maintenance of chronic inflammation in AD [27].”
Zhang, C., Yang, Y.-S., Pei, M.-Q., Chen, X.-L., Chen, W.-C., & He, H. (2024) · Clinical Interventions in Aging · doi:10.2147/cia.s462471 · Cited by 18
“41 This suggests that the mechanisms underlying cerebral hypoxia-mediated impairment of cognitive function overlap with those involved in the pathogenesis of POCD.”
BackgroundHu, X., Liu, C., Wang, K., Zhao, L., Qiu, Y. L., Chen, H., Hu, J., & Xu, J. (2022) · Frontiers in Chemistry · doi:10.3389/fchem.2022.842208 · Cited by 15
The Role of Circadian Rhythm in Neurological Diseases: A Translational Perspective
Huang, W., Zong, J., Zhang, Y. L., Zhou, Y., Zhang, L., Wang, Y., Shan, Z., Xie, Q., Li, M., Pan, S., et al. (2023) · Aging and Disease · doi:10.14336/ad.2023.0921 · Cited by 26
“Furthermore, dysfunction of the BBB has been linked to increased production of Aβ [101].”
BackgroundBall, B. K., Kuhn, M. K., Fleeman, R. M., Proctor, E. A., & Brubaker, D. K. (2024) · Scientific Reports · doi:10.1038/s41598-024-62155-3 · Cited by 17
Salminen, A. (2024) · European Journal of Neuroscience · doi:10.1111/ejn.16450 · Cited by 15
“It is known that the loss of BBB integrity and neuroinflammation are associated with cognitive impairment and AD pathogenesis (Barisano et al., 2022; Cai et al., 2018).”
Saponin components in Polygala tenuifolia as potential candidate drugs for treating dementia
Li, S., Hou, Z., Ye, T., Song, X., Hu, X., & Chen, J. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1431894 · Cited by 23
Antonioni, A., Raho, E. M., Manzoli, L., Koch, G., Flacco, M. E., & Lorenzo, F. D. (2025) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1002/dad2.70068 · Cited by 24
Radiation Exposure Induced Blood–Brain Barrier Injury via Mitochondria‐Mediated Sterile Inflammation
Wang, P., Liu, J., Zhang, M., Yang, J., Lian, P., Cheng, X., & Qin, J. (2025) · Advanced Science · doi:10.1002/advs.202502356 · Cited by 29
The Blood−Brain Barrier in Neuroimmune Interactions and Pathological Processes
Dyatlova, A. S., Novikova, N. S., Yushkov, B. G., Korneva, E. A., & Черешнев, В. А. (2022) · Herald of the Russian Academy of Sciences · doi:10.1134/s1019331622050100 · Cited by 19
Signal Pathways and Intestinal Flora through Trimethylamine N-oxide in Alzheimer's Disease
Zhang, Y., & Jian, W. (2023) · Current Protein and Peptide Science · doi:10.2174/1389203724666230717125406 · Cited by 14
Wu, W., Huang, J., Han, P., Zhang, J., Wang, Y., Jin, F., & Zhou, Y. (2023) · Molecules · doi:10.3390/molecules28227631 · Cited by 15
“…BBB dysfunction interacts with tau pathology by inducing hyper-phosphorylation of the tau protein, leading to the formation of NFTs. Additionally, certain tau proteins can cross the BBB in both directions, exacerbating tau pathology and contributing to BBB damage (Figures 2 and 4) [9,65–68].”
BackgroundInfluentialYassaghi, Y., Nazerian, Y., Ghasemi, M., Nazerian, A., Sayehmiri, F., Perry, G. L., & Pourbadie, H. G. (2024) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.18554 · Cited by 15
“35,41 The BBB disruption spreads peripheral inflammation into the CNS mainly due to direct contact with inflamed endothelial cells and FIGURE 1 Role of microglia in molecular pathways involved in AD.”
BackgroundMiceli, V., Russelli, G., Iannolo, G., Gallo, A., Re, V. L., Agnese, V., Sparacia, G., Conaldi, P. G., & Bulati, M. (2020) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2020.111332 · Cited by 15
Possible effects of Porphyromonas gingivalis on the blood–brain barrier in Alzheimer’s disease
Olsen, I. (2021) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2021.1925540 · Cited by 17
“A correlation between BBB dysfunction and tau pathology has been reported [5].”
BackgroundRelationship of amyloid-β1–42 in blood and brain amyloid: Ginkgo Evaluation of Memory Study
López, O. L., Klunk, W. E., Mathis, C. A., Snitz, B. E., Chang, Y., Tracy, R. P., & Kuller, L. H. (2019) · Brain Communications · doi:10.1093/braincomms/fcz038 · Cited by 15
Ferrari, I., Limiti, E., Giannitelli, S. M., Trombetta, M., Rainer, A., D’Amelio, M., Barbera, L. L., & Gori, M. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26199478 · Cited by 15
“In addition, growing evidence indicates that blood–brain barrier (BBB) dysfunction and deterioration, closely associated with vascular risk factors, are among the pathophysiological features of AD [11].”
Bibliometric analysis of neuroinflammation and Alzheimer’s disease
Sun, W., Gong, J., Li, S., Pin, W., Han, X., Chang, X., Luan, H., Li, R., Wen, B., & Wei, C. (2024) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2024.1423139 · Cited by 17
“This accumulation further disrupts BBB function, perpetuating a detrimental cycle that ultimately results in cognitive decline (Cai et al., 2018).”
BackgroundWen, C., Gan, J., Liu, S., Lu, H., Wang, L.-C., Wu, H., Shi, Z.-H., & Ji, Y. (2025) · Journal of Alzheimer s Disease · doi:10.1177/13872877251317220 · Cited by 14
“47 An imbalance between A β production and clearance was shown to result in the aggregation of A β in the vessel wall and possibly slow down the polarization of AQP4 channels and water transport across the BBB. 48,49 In a histo-pathological study, increased vascular A β accumulation was observed…”
Pokrzyk, J., Kulczyńska‐Przybik, A., Guzik-Makaruk, E. M., Winkel, I., & Mroczko, B. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26051935 · Cited by 16
“Nonetheless, central nervous system vascular disease, often associated with Alzheimer’s disease, remains a major factor in BBB dysfunction [25].”
Wang, Y., Wang, Q., Luo, D., Zhao, P., Zhong, S.-S., Dai, B., Wang, J.-J., Wan, Y.-T., Liu, Z., & Yang, H. (2023) · Chinese Journal of Integrative Medicine · doi:10.1007/s11655-023-3592-5 · Cited by 19
“(16) Previous studies have demonstrated that Aβ depositions are closely related to the permeability of BBB.(11,17,18) The BBB, composed of a parenchyma microvascular endothelial cell basement membrane and foot processes of astrocytes, restricts the free passage of cells and molecules from the systemic compartment into…”
BackgroundInfluentialChen, X., Mao, Y., Guo, Y., Xiao, D., Lin, Z., Huang, Y., Liu, Y. C., Zhang, X., & Wang, Y. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-04071-0 · Cited by 15
“deposition compared to the WT rats The BBB dysfunction induces the failure of amyloid-β (Aβ) protein transport from brain to the peripheral circulation across the BBB and involves in the pathogenesis of Alzheimer’s disease (AD) [28].”
BackgroundPeripheral immune and metabolic regulation of Aβ and Tau by exercise in Alzheimer’s disease
Yu, Y., & Chen, K. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1678526 · Cited by 14
“BBB dysfunction is recognized as an early and critical event in the pathogenesis of AD (134).”
Environmental mycotoxins: A potential etiological factor for neurodegenerative diseases?
Nie, T., Li, J., You, L., & Wu, Q. (2025) · Toxicology · doi:10.1016/j.tox.2025.154056 · Cited by 15
Stevenson, T. K., Moore, S. J., Murphy, G. G., & Lawrence, D. A. (2021) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-0041-1740265 · Cited by 12
Raut, S., Patel, R., Pervaiz, I., & Al-Ahmad, A. J. (2022) · NeuroToxicology · doi:10.1016/j.neuro.2022.01.007 · Cited by 13
Perspectives on Alzheimer’s Disease Treatment Based on Counteracting Oxidative Stress
Bilski, R., Dąbkowski, S., Kozieł, I., Kozicki, M., Małachowska, A., Przygocki, M., & Tyska, O. (2025) · Biomolecules · doi:10.3390/biom15091345 · Cited by 13
“Damage to the blood–brain barrier exacerbates the CNS’s exposure to toxic environmental factors and intensifies the inflammatory response [30].”
León-Arcia, K., Andrade-Guerrero, J., Martínez-Orozco, H., Villegas-Rojas, M. M., Pérez-Segura, I., Ramírez, I. L., Vilches‐Flores, A., Guerra‐Crespo, M., Díaz-Miranda, S. Y., & Soto-Rojas, L. O. (2025) · Ageing Research Reviews · doi:10.1016/j.arr.2025.102918 · Cited by 15
Tu, H., Chao, M., Lee, C., Peng, C.-S., Wu, Y., Lin, T. E., Chang, Y.-W., Yen, S., Hsu, K., Pan, S., et al. (2024) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756366.2024.2418470 · Cited by 10
“The BBB is composed of selective semipermeable endothelial cells that protect our brains from foreign invaders. however, this protective nature also poses a challenge by impeding the effectiveness of drugs intended to treat cNs diseases 40 .”
Maazouzi, M., Rasheed, M., Mbarek, L., Wang, X., Liang, J., Ma, H., Chen, Z., & Deng, Y. (2025) · Journal of Neurochemistry · doi:10.1111/jnc.70031 · Cited by 12
Sharma, H. S., Muresanu, D. F., Nozari, A., Lafuente, J. V., Buzoianu, A. D., Sahib, S., Tian, Z. R., Bryukhovetskiy, I., Manzhulo, I., Menon, P. K., et al. (2021) · Progress in brain research · doi:10.1016/bs.pbr.2021.04.008 · Cited by 12
Wang, C., Kong, J., Xue, C., Zhang, T., & Wang, Y. (2023) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202200825 · Cited by 12
Systems biology of Alzheimer’s Disease: a scoping review of key pathways and mechanisms
Bice, P. J., Nho, K. T., Ertekin‐Taner, N., & Saykin, A. J. (2026) · Molecular Neurodegeneration · doi:10.1186/s13024-026-00934-4 · Cited by 18
“Other transporters, including increased levels of RAGE (receptor for advanced glycation end products) and decreased levels of LRP1 (low density lipoprotein receptor-related protein-1) also cause dysfunction of Aβ transport in the BBB [90].”
Metadata
- Authors
- Cai, Z., Qiao, P.-F., Wan, C.-Q., Cai, M., Zhou, N.-K., & Li, Q.
- Affiliations
- Department of Neurology, Chongqing General Hospital, Chongqing, Chongqing, China
- Corresponding author
- Cai, Zhiyou
- Venue
- Journal of Alzheimer's Disease
- Publisher
- SAGE Publications
- Published
- 2018-05-30
- Volume
- 63
- Issue
- 4
- Pages
- 1223-1234
- ISSN
- 1387-2877 (ISSN-L)
- 1875-8908
- OpenAlex
- W2804234159
- Cited by
- 370
- References
- 133
- Citations by year
- 2026: 31 · 2025: 59 · 2024: 63 · 2023: 69 · 2022: 49 · 2021: 63 · 2020: 25 · 2019: 10 · 2018: 1
- FWCI
- 2.34
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Alzheimer s Disease (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Keywords
- blood-brain barrier, Alzheimer's disease
- MeSH terms
- Receptor for Advanced Glycation End Products, Alzheimer Disease, Blood-Brain Barrier, Humans, Amyloid beta-Peptides, Low Density Lipoprotein Receptor-Related Protein-1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.